Intra-operatieve fluorescente beeldvorming alvleesklier tumoren en galwegen.
Completed
- Conditions
- Pancreatic cancer, pancreas, bile ducts
- Registration Number
- NL-OMON24019
- Lead Sponsor
- eiden University Medical Center (LUMC)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
1. Patients diagnosed with pancreatic cancer eligible to undergo a curative resection;
2. Age between 18 and 80 years old.
Exclusion Criteria
1. No History of allergy to iodine, shellfish, indocyanine green, human serum albumin and/or history of hyperthyroidism or severe renal impairment;
2. Patient pregnant or lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome parameter is the number of identified pancreatic tumors.
- Secondary Outcome Measures
Name Time Method Secundary parameters are the differences in tumor-to-background ratios measured in patients that recieved different amounts of ICG. Furthermore, the fluorescence of bile ducts on different time-points after injection. Another secundary outcome parameter is the lymfatic drainage pattern of a pancreatic tumor.